Medha Analytics - Advanced analytics & AI, Narayana Health, Bengaluru, India.
Department of Cardiothoracic Surgery, Narayana Health, India.
Asian Cardiovasc Thorac Ann. 2023 May;31(4):348-356. doi: 10.1177/02184923231171493. Epub 2023 Apr 26.
The aim of this study was to develop a new risk prediction score (NH Score) for patients undergoing coronary artery bypass grafting (CABG) specific to the Indian population and compare it to the Society of Thoracic Surgeon (STS) Score and the EuroSCORE II.
The baseline features of adult patients who underwent CABG between the years 2015 and 2021 ( = 6703) were taken and split into training data (2015-2020; = 5561) and validation data (2020-2021; = 1142). The CatBoost algorithm was trained to predict risk scores (NH score), and the performance was tested on the validation set by Precision-Recall Curve and F1 Score. Model calibration was measured by the Brier Score, Expected Calibration Error and Maximum Calibration Error.
The NH score outperformed both the STS and EuroSCORE II for all outcomes. For mortality, the PR AUC for NH Score was (0.463 [95% confidence interval [CI], 0.28-0.64]) compared to 0.113 [95% CI, 0.04-0.22] for the STS score and 0.146 [95% CI, 0.06-0.31] for the EuroSCORE II ( ≪ 0.0001). With respect to morbidity NH Score was superior to the STS score (0.43 [95% CI, 0.33-0.50]) vs. (0.229 [95% CI, 0.18-0.3, < 0.0001). The observed to the predicted ratio for NH score was superior to the STS Score and similar to EuroSCORE II. NH Score was also more accurate at predicting the risk of prolonged ventilation compared to the STS Score.
NH score shows an excellent improvement over the performance of STS score and EuroSCORE II for modelling risk predictions for patients undergoing CABG in Indian population. It warrants further validation for larger datasets.
本研究旨在为印度人群开发一种新的冠状动脉旁路移植术(CABG)患者风险预测评分(NH 评分),并与胸外科医师学会评分(STS 评分)和欧洲心脏手术风险评估系统 II 评分(EuroSCORE II)进行比较。
纳入 2015 年至 2021 年期间接受 CABG 的成年患者的基线特征(n=6703),并将其分为训练数据(2015-2020 年;n=5561)和验证数据(2020-2021 年;n=1142)。使用 CatBoost 算法对风险评分(NH 评分)进行预测,并通过精确-召回曲线和 F1 评分在验证数据上进行性能测试。模型校准通过 Brier 评分、预期校准误差和最大校准误差来衡量。
在所有结局中,NH 评分均优于 STS 评分和 EuroSCORE II 评分。对于死亡率,NH 评分的 PR AUC 为(0.463 [95%置信区间 [CI],0.28-0.64]),而 STS 评分的为 0.113 [95% CI,0.04-0.22],EuroSCORE II 的为 0.146 [95% CI,0.06-0.31]( ≪ 0.0001)。在发病率方面,NH 评分优于 STS 评分(0.43 [95% CI,0.33-0.50])(0.229 [95% CI,0.18-0.3, < 0.0001)。NH 评分的观察到的预测比与 STS 评分的观察到的预测比更优,与 EuroSCORE II 的相似。NH 评分在预测 CABG 患者长时间通气的风险方面也比 STS 评分更准确。
NH 评分在印度人群中对 CABG 患者的风险预测模型的性能优于 STS 评分和 EuroSCORE II,具有显著的改善。需要进一步在更大的数据集上进行验证。